Skip to main content

A dual compression system: preliminary clinical insights from the US

John C Lantis 2nd  1 Christopher Barrett  2 Kara S Couch  3 Suzie Ehmann  4 Emily Greenstein  5 Marta Ostler  6 Anthony Tickner  7



There is growing evidence on an interconnection between the venous and lymphatic systems in venous leg ulceration, and the possible effects of prolonged oedema and lymphatic impairment in delayed wound healing.

Compression therapy is a widely accepted treatment for venous and lymphatic disorders, as it decreases recurrence rates and prolongs the interval between recurrences. Compression bandages improve venous return, increase the volume and rate of venous flow, reduce oedema and stimulate anti-inflammatory processes.

The pressure at the interface (IP) of the bandage and the skin is related to the elastic recoil of the product used and its resistance to expansion. The pressure difference between the IP in the supine and standing positions is called the static stiffness index (SSI). Elastic materials provide little resistance to muscle expansion during physical activity, resulting in small pressure differences between resting and activity, with an SSI <10mmHg. Stiff, inelastic materials with a stretch of <100% resist the increase of muscle volume during physical activity, producing higher peak pressures, an SSI of >10mmHg and a greater haemodynamic benefit than elastic systems. UrgoK2 is a novel dual-layer high-compression system consisting of an inelastic (short stretch) and elastic (long stretch) bandage, resulting in sustained tolerable resting pressure and elevated working pressures over extended wear times.

It is indicated for the treatment of active venous leg ulcers and the reduction of chronic venous oedema. Each bandage layer has a visual aid to enable application at the correct pressure level. Published European studies have assessed this compression system, exploring its consistency of application, tolerability and efficacy. This article presents the first reports of health professionals’ clinical experience of using the compression system in the US, where it has been recently launched. Initial feedback is promising.

Originally Published-National Library of Medicine, September 2020

You Might Also Enjoy...

Recent Lapiplasty at Saint Vincent Hospital

THEE Saint Vincent Hospital Another satisfied customer. Thank you, Steven Quan for the assist and Weldon Murry, Elizabeth Ansert, Samuel Gorelik, and the rest of the surgical residents and staff for always making our cases and patients lives easier.

Debunking Common Barriers Cited for Avoiding TCC Use

We are great at putting things on DFUs. Why are we so bad at taking the most critical thing off? Diabetic foot ulceration (DFU) is currently the leading cause of diabetes-related hospitalization and non-traumatic lower extremity amputation.

When Might One Increase Pressure Settings In NPWT?

Since the development and Food and Drug Administration (FDA) approval of negative pressure wound therapy (NPWT) in 1995, it has been used in a wide range of wound types.1 Clinical applications have increased and undergone extensive study...

Other Publications

The Zebras: An Overview of Atypical Wounds August 2021, Submitted for PublicationTotal Contact Cast Use in Patients with Peripheral Arterial Disease: A Case Series and Systematic Review Nov 2018, WOUNDS